Integrated demonstration
Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.
Load EXP-0885 · Site E · 15 November 2026Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.
Which intelligence is being demonstrated?
- Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
- Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
- Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
- Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads
Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.
- Direct entry with mobile-friendly forms and future offline capabilities.
- Validated CSV/Excel imports with schema, chronology and data-quality checks.
- Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.
Programme dashboard
Screening activity and follow-up across the synthetic programme.
Programme activity
- Unique participants screened
- 4,325
- Screening encounters
- 5,499
- Diagnostic referrals
- 1,045
- Outstanding pathways
- 320
Screening pathway
- Screening5,499Encounters
- Positive finding1,939Documented findings
- Referral1,045Diagnostic referrals
- Follow-up1,284Diagnostic visits
- Outcome725Resolved pathways
Stage totals use different units. Pending pathways: 285. Insufficient observation: 35.
Participant insight
Expanded synthetic participant 0175 · EXP-0175Synthetic · Site B
Full participant history through 2027-08-09, across modalities and pathways.
- · Screening · VIA · Initial · Programme entry
- · Screening result · VIA · VIA positive · Adequate
- · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-07-24
- · Diagnostic referral · EXP-0175-T-R
- · Contact attempt · Reached
- · Diagnostic booking · Initial booking
- · Diagnostic visit · Attended
- · Diagnosis · Colposcopy · Biopsy collected
- · Diagnosis · Histopathology · No high-grade lesion identified
- · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-03-20
- · Follow-up disposition · Resolved · EXP-0175-T-R
- · Screening · HPV DNA · Repeat · Prior VIA positive
- · Screening result · HPV DNA · HPV detected · Adequate
- · Surveillance · HPV DNA · Surveillance · After clinical assessment
- · Surveillance result · HPV DNA · HPV detected · Adequate
Referral-time risk
Pathway status at observation · Resolved
Loading prediction…
Observed day-60 outcome · Resolved
Screened participants
4325 matching participants. Select a participant to review their timeline and referral-time risk.
Programme insights
Encounters by modality
- VIA
- 1970
- HPV DNA
- 2802
- Cytology
- 727
Navigation activity
- Barrier documented
- 937
- Contact attempt
- 1505
- Navigation intervention
- 417
- Diagnostic booking
- 1301
- Diagnostic visit
- 1284
Documented barriers
- Contact difficulty
- 298
- Transport difficulty
- 311
- Appointment coordination
- 328
Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.